KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Inventory Average (2016 - 2025)

Biomarin Pharmaceutical's Inventory Average history spans 16 years, with the latest figure at $1.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 11.16% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, up 11.16%, and an annual FY2025 reading of $1.3 billion, up 8.19% over the prior year.
  • Inventory Average for Q4 2025 was $1.3 billion at Biomarin Pharmaceutical, down from $1.4 billion in the prior quarter.
  • The five-year high for Inventory Average was $1.4 billion in Q3 2025, with the low at $706.2 million in Q1 2021.
  • Average Inventory Average over 5 years is $1.0 billion, with a median of $975.5 million recorded in 2023.
  • Year-over-year, Inventory Average fell 1.7% in 2021 and then increased 23.84% in 2024.
  • Tracing BMRN's Inventory Average over 5 years: stood at $763.0 million in 2021, then rose by 13.59% to $866.8 million in 2022, then grew by 23.41% to $1.1 billion in 2023, then rose by 12.74% to $1.2 billion in 2024, then increased by 11.16% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Inventory Average are $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025).